Assessment of the effect of nebivolol and сarvedilol on the functional state of patients with diastolic chronic heart failure

Cover Page

Cite item

Full Text

Abstract

Aim. To determine the effect of combined therapy with nebivolol or carvedilol on the functional state of patients with diastolic chronic heart failure (CHF).

Material and methods. The study involved 68 patients with CHF and preserved left ventricular ejection fraction, who were randomized into two groups for treatment with bisoprolol or carvedilol. As part of the combination therapy was prescribed quinapril, and if indicated – atorvastatin, acetylsalicylic acid in the intestinal soluble shell. Initially and after 24 weeks of therapy were carried out: quantitative assessment of regulatory-adaptive status (RAS), echocardioscopy, treadmill test, six-minute walking test, subjective assessment of quality of life, determination of level of N-terminal fragment of the brain natriuretic peptide precursor in blood plasma.

Results. Both schemes of combined therapy comparably improved the morpho-functional parameters of the heart and quality of life. In comparison with carvedilol, nebivolol more pronouncedly increased RAS and tolerance to physical activity.

Conclusion. In patients with diastolic CHF in combination therapy, the use of nebivolol, in comparison with carvedilol, may be preferable due to the positive effect on the functional state.

About the authors

Vitalii G. Tregubov

Kuban State Medical University

Author for correspondence.
Email: vgtregubov@mail.ru

D. Sci. (Med.)

Russian Federation, Krasnodar

Pavel V. Khil′kevich

Kuban State Medical University

Email: vitiorus@mail.ru

Graduate Student

Russian Federation, Krasnodar

Iosif Z. Shubitidze

Regional Clinical Hospital №2

Email: iosif.shubitidze@mail.ru

cardiologist

Russian Federation, Krasnodar

Anna V. Tregubova

Kuban State Medical University

Email: tregubova-anna@mail.ru

Student

Russian Federation, Krasnodar

References

  1. Мареев В.Ю., Фомин И.В., Агеев Ф.Т. и др. Клинические рекомендации. Хроническая сердечная недостаточность. Сердечная недостаточность. 2017; 18 (1): 3–40. doi: 10.18087/cardio.2475 [Mareev V.Y., Fomin I.V., Ageev F.T. et al. Clinical guidelines. Chronic heart failure (CHF). Russian Heart Failure Journal. 2017; 18 (1): 3–40. doi: 10.18087/cardio.2475 (in Russian).]
  2. Hunt SA, Abraham WT, Chin MH et al. Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A report of American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation. J Am Сoll Сardiol 2009; 53 (15): 1–90. doi: 10.1161/CIRCULATIONAHA.109.192065
  3. Покровский В.М., Потягайло Е.Г., Абушкевич В.Г. и др. Сердечно-дыхательный синхронизм: выявление у человека, зависимость от свойств нервной системы и функциональных состояний организма. Успехи физиологических наук. 2003; 34 (3): 68–77. [Pokrovsky V.M., Potiagaylo E.G., Abushkevich V.G. et al. Cardio-respiratory synchronism: detection in humans, dependence on the properties of the nervous system and functional states of the body. Advances in physiological sciences. 2003; 34 (3): 68–77 (in Russian).]
  4. Покровский В.М., Пономарев В.В., Артюшков В.В. и др. Система для определения сердечно-дыхательного синхронизма у человека. Россия, патент №86860, 2009 г. [Pokrovsky V.M., Ponomarev V.V., Artyushkov V.V. et al. System for determining cardio-respiratory synchronism in humans. Russia, patent №86860, 2009 (in Russian).]
  5. Rector TS, Kubo SH, Cohn JN. Patient’s self assessment of their congestive heart failure. Part 2: Content, reliability and validity of a new measure. The Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987; 3: 198–209.
  6. Трусова Я.О. Регуляторно-адаптивный статус студентов с усиленной физической нагрузкой. Кубанский научный мед. вестн. 2016; 6: 128–31. doi: 10.25207/1608-6228-2016-6-128-131 [Trusova Y.O. Regulatory-adaptive status of the students with enhanced physical activity. Kuban Scientific Medical Bulletin. 2016; 6: 128–31. doi: 10.25207/1608-6228-2016-6-128-131 (in Russian).]
  7. Pokrovsky VM, Polischuk LV. Cardiorespiratory synchronism in estimation of regulatory and adaptive organism status. J Integr Neurosci 2016; 15 (1): 19–35. doi: 10.1142/S0219635216500060
  8. Трегубов В.Г., Канорский С.Г., Покровский В.М. Количественная оценка регуляторно-адаптивного статуса в определении прогноза при систолической хронической сердечной недостаточности. Клин. медицина. 2015; 93 (11): 22–8. [Tregubov V.G., Kanorsky S.G., Pokrovsky V.M. Quantitative assessment of the regulatory-adaptive status in determining the prognosis for systolic chronic heart failure. Clinical Medicine. 2015; 93 (11): 22–8 (in Russian).]
  9. Шубитидзе И.З., Трегубов В.Г. Оценка влияния b-адреноблокаторов на функциональное состояние пациентов с желудочковыми нарушениями ритма сердца: результаты сравнительного исследования. CardioСоматика. 2020; 11 (2): 19–24. doi: 10.26442/22217185.2020.2.200266 [Shubitidze I.Z., Tregubov V.G. Assessment of the effect of b-blockers on the functional state in patients with ventricular arrhythmias: results of a comparative study. Cardiosomatics. 2020; 11 (2): 19–24. doi: 10.26442/22217185.2020.2.200266 (in Russian).]
  10. Трегубов В.Г., Еремина М.А., Канорский С.Г., Покровский В.М. Сравнение эффективности терапии у пациентов с пароксизмальной фибрилляцией предсердий. Кардиоваскулярная терапия и профилактика. 2017; 16 (2): 46–51. doi: 10.15829/1728-8800-2017-2-46-51 [Tregubov V.G., Eremina M.A., Kanorsky S.G., Pokrovsky V.M. Comparison of treatment efficacy in paroxysmal atrial fibrillation. Cardiovascular Therapy and Prevention. 2017; 16 (2): 46–51. doi: 10.15829/1728-8800-2017-2-46-51 (in Russian).]
  11. Нажалкина Н.М., Трегубов В.Г., Покровский В.М. Регуляторно-адаптивный статус в определении эффективности небиволола и соталола у пациентов с пароксизмальной суправентрикулярной тахикардией и гипертонической болезнью. Кардиология. 2017; 57 (1S): 345–54. doi: 10.18087/cardio.2396 [Nazhalkina N.M., Tregubov V.G., Pokrovsky V.M. Regulatory adaptive status in determining the effectiveness of bisoprololum and sotalolum in patients with hypertensive disease and paroxysmal supraventricular tachycardia. Kardiologiia. 2017; 57 (1S): 345–54. doi: 10.18087/cardio.2396 (in Russian).]
  12. Марцевич С.Ю., Захарова Н.А., Кутишенко Н.П. и др. Практика применения b-адреноблокаторов у больных с сердечно-сосудистыми заболеваниями при хронических болезнях органов дыхания. Данные амбулаторных регистров ПРОФИЛЬ и РЕКВАЗА. Рацион. фармакотерапия в кардиологии. 2017; 13 (4): 469–75. doi: 10.20996/1819-6446-2017-13-4-469-475 [Martsevich S.Y., Zakharova N.A., Kutishenko N.P. et al. Сlinical practice of b-blockers usage in patients with cardiovascular and chronic respiratory diseases. Data of outpatient registries PROFILE and RECVASA. Rational Pharmacotherapy in Cardiology. 2017; 13 (4): 469–75. doi: 10.20996/1819-6446-2017-13-4-469-475 (in Russian).]
  13. Frоhlich H, Torres L, Tаger T et al. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clin Res Cardiol 2017; 106 (9): 711–21. doi: 10.1007/s00392-017-1115-0

Copyright (c) 2020 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies